|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22.10.26 - 13:06
|
Foundation Medicine Appoints Chadi Nabhan, M.D., MBA, as Chief Medical Officer (Business Wire)
|
|
|
BOSTON--(BUSINESS WIRE)--Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced the appointment of Chadi Nabhan, M.D., MBA, as chief medical officer, effective November 16, 2026. In this role, Dr. Nabhan will lead the company's global medical affairs and clinical development, accelerating precision oncology for patients at every stage of the disease.
Dr. Nabhan brings more than two decades of extensive leadership experience across clinical oncology, academic research, genomics and healthcare technology. Most recently, he served as chief medical officer at Ryght, where he championed the integration of artificial intelligence to optimize clinical trials and research site selection. Prior to that, he was senior vice president and chairman of the Precision Oncology Alliance at Caris Life Sciences, where he expanded the organization's collaborative oncology research network to strengthen precision cancer care for patients. Earlier in his career, he held key positions...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|